A. Szoke

发表

The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study

Peter B. Jones, R. Murray, E. Vassos, 2019, bioRxiv.

Different rates of first admissions for psychosis in migrant groups in Paris

R. Murray, C. Morgan, A. Tortelli, 2013, Social Psychiatry and Psychiatric Epidemiology.

Small area-level variation in the incidence of psychotic disorders in an urban area in France: an ecological study

M. Leboyer, F. Schürhoff, B. Pignon, 2016, Social Psychiatry and Psychiatric Epidemiology.

First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data

E. Vassos, S. Tosato, P. Sham, 2022, Schizophrenia bulletin.

3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort

B. Aouizerate, G. Fond, F. Berna, 2022, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Schizophrenia and other psychotic disorders in Caribbean-born migrants and their descendants in England: systematic review and meta-analysis of incidence rates, 1950–2013

R. Murray, P. Jones, A. Szöke, 2015, Social Psychiatry and Psychiatric Epidemiology.

A SNAP25 PROMOTER VARIANT IS ASSOCIATED WITH SCHIZOPHRENIA AND A DISTURBED SNAP25B/SNAP25A EXPRESSION RATIO IN PATIENTS

M. Leboyer, C. Lançon, P. Llorca, 2010, Schizophrenia Research.

INFLUENCE OF PATERNAL AGE IN SCHIZOPHRENIA

M. Leboyer, A. Méary, F. Schurhoff, 2010, Schizophrenia Research.

The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort

M. Leboyer, B. Aouizerate, G. Fond, 2022, European Archives of Psychiatry and Clinical Neuroscience.

Pilot study of the relationship between psychotic manifestations and living environment

A. Szöke, B. Pignon, H. Charreire, 2020 .

Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia

M. Leboyer, B. Aouizerate, G. Fond, 2022 .

Executive deficits in psychotic and bipolar disorders – Implications for our understanding of schizoaffective disorder

M. Leboyer, F. Bellivier, A. Méary, 2008, European Psychiatry.

Common variant at 16p11.2 conferring risk of psychosis

M. Pirinen, H. Stefánsson, D. Rujescu, 2014, Molecular Psychiatry.

Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study

M. Leboyer, B. Aouizerate, G. Fond, 2021, Schizophrenia bulletin open.

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.

D. Rujescu, R. Murray, M. Ruggeri, 2014, Schizophrenia bulletin.

Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis

M. Leboyer, R. Yolken, G. Fond, 2015, Acta psychiatrica Scandinavica.

Schizophrenia: Developmental Variability Interacts with Risk Factors to Cause the Disorder

B. Pignon, S. Jamain, A. Szoke, 2020, BioEssays : news and reviews in molecular, cellular and developmental biology.

Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.

M. Leboyer, B. Aouizerate, G. Fond, 2020, Journal of affective disorders.

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

M. Leboyer, J. Os, J. Honnorat, 2013, Front. Genet..

Association between cannabis use and schizotypal dimensions – A meta-analysis of cross-sectional studies

M. Leboyer, J. Richard, G. Baudin, 2014, Psychiatry Research.

Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study.

M. Leboyer, B. Aouizerate, G. Fond, 2021, Schizophrenia bulletin.

Childhood trauma and psychosis: Beyond the association.

M. Leboyer, A. Pelissolo, J. Richard, 2017, Child abuse & neglect.

Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort

M. Leboyer, B. Aouizerate, G. Fond, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Tobacco use in first-episode psychosis, a multinational EU-GEI study.

J. Sanjuán, J. van Os, M. Arrojo, 2023, Psychological medicine.

Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort

M. Leboyer, B. Aouizerate, G. Fond, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort

B. Aouizerate, F. Berna, C. Lançon, 2022, European Archives of Psychiatry and Clinical Neuroscience.

Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.

M. Leboyer, B. Aouizerate, G. Fond, 2023, Journal of psychiatric research.

Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders

T. Bourgeron, R. Delorme, C. Gillberg, 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia

F. Berna, R. Joober, P. Sunhary de Verville, 2022, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.

D. Rujescu, M. Ruggeri, S. Tosato, 2014, Schizophrenia bulletin.

Multimorbidity and the Etiology of Schizophrenia.

A. Ferchiou, A. Szoke, F. Schürhoff, 2024, Current psychiatry reports.